8-K: DIH Holding US Strengthens Scientific Advisory Board with Key Neurorehabilitation Expert Appointment

DIH Holding US, Inc. announced the appointment of Professor Nick Ward, M.D., a distinguished expert in neurorehabilitation, to its Scientific Advisory Board, enhancing its commitment to evidence-based innovation.

Summary

• DIH Holding US, Inc. (NASDAQ: DHAI) appointed Professor Nick Ward, M.D., to its Scientific Advisory Board on July 15, 2025.
• Professor Ward is a Professor of Clinical Neurology and Neurorehabilitation at the Institute of Neurology at University College London and at the National Hospital for Neurology and Neurosurgery in London, UK.
• His expertise includes upper limb neurorehabilitation, leading a dedicated high-intensity program, and investigating neurobiological mechanisms involved in the recovery of arm and hand functions.
• The DIH Scientific Advisory Board (SAB) advises the company on technical and scientific pursuits, offers insights into the latest trends in clinical and scientific communities, provides feedback on product development, and advises on research plans and projects.
• With this appointment, the DIH Scientific Advisory Board now comprises nine distinguished members.
• DIH is a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance, and/or impaired arm and hand functions.

Sentiment

Score: 7

Explanation: The appointment of a highly respected expert to the Scientific Advisory Board is a positive step for DIH, enhancing its scientific credibility and potential for innovation in neurorehabilitation. This strengthens the company's strategic direction and commitment to evidence-based solutions.

Positives

• Appointment of Professor Nick Ward, M.D., a highly distinguished clinical expert in upper limb neurorehabilitation, to the Scientific Advisory Board.
• Professor Ward's pioneering research and commitment to high-intensity training and evidence-based rehabilitation are invaluable additions to DIH's strategic direction.
• Strengthens the Scientific Advisory Board to nine distinguished members, reinforcing the company's commitment to evidence-based innovation and clinical excellence in neurorehabilitation.
• The SAB provides critical guidance on technical and scientific pursuits, product development, and research plans, which can enhance DIH's advanced rehabilitation solutions.

Risks

• General economic, political, and business conditions could adversely affect DIH's operations and financial results.
• The ability of DIH to achieve its projected revenue is subject to various uncertainties.
• Failure to realize the anticipated benefits of the recently-completed business combination could impact the company.
• Potential challenges in accessing sources of additional debt or equity capital if needed.

Future Outlook

DIH aims to continue transforming the standard of care in rehabilitation through advanced technologies, with Professor Ward's guidance playing a pivotal role in shaping innovation and impact. The company's vision is to deliver inspiration and health by improving the daily lives of millions of people with disabilities and functional impairments through intensive rehabilitation solutions.

Management Comments

• "We are honored to welcome Professor Nick Ward to the DIH Scientific Advisory Board. Nicks exceptional clinical expertise in upper limb rehabilitation, his pioneering research and his unwavering commitment to high-intensity training and evidence-based rehabilitation make him an invaluable addition. As DIH continues to transform the standard of care in rehabilitation through advanced technologies, Nicks guidance will play a pivotal in shaping our innovation and impact." Dr. Bettina Studer Pastore, Global Head of Scientific and Clinical Affairs at DIH.
• "Im delighted to be joining the DIH Scientific Advisory Board at this exciting time in neurorehabilitation. I hope to be able to bring some clinical experience to bear on the future of new approaches to support motor recovery after stroke." Professor Nick Ward.

Industry Context

The appointment of a leading neurorehabilitation expert like Professor Ward highlights the ongoing trend in the medical device and rehabilitation industry towards evidence-based innovation and the integration of advanced technologies, particularly robotics, to improve patient outcomes. It also reflects a focus on specialized areas like upper limb recovery, which is a significant challenge in neurorehabilitation, indicating DIH's commitment to addressing critical patient needs.

Comparison to Industry Standards

• NA

Corporate Governance

Stakeholder Impact

• Shareholders: Positive impact on company's long-term strategic direction and credibility, potentially leading to better product development and market positioning.
• Patients/Customers: Potential for improved and more effective rehabilitation solutions due to enhanced scientific guidance.
• Employees: Strengthens the company's scientific foundation and commitment to innovation, potentially fostering a more robust R&D environment.

Next Steps

• Professor Ward will advise DIH on technical and scientific pursuits, provide insights into clinical and scientific trends, offer feedback on product development, and advise on research plans and projects.
• DIH will continue its efforts to transform the standard of care in rehabilitation through advanced technologies.

Key Dates

Recommendation

Keywords

DIH Holding US, DHAI, Neurorehabilitation, Robotic Devices, Rehabilitation Technology, Scientific Advisory Board, Nick Ward, Upper Limb Rehabilitation, Stroke Recovery, Medical Devices, Healthcare Technology